Taiwan approves use of oral CDK4/6 suppressants

Taiwan approves use of oral CDK4/6 suppressants

Taiwan’s health authorities have approved the use of oral CDK4/6 targeting suppressants to treat HER2 negative breast cancer for late stage/recurrence metastasis patients.

CDK4/6 are cyclin dependent kinases 4/6.  Inhibitors of CDK4/6 trigger anti-tumor immunity and induce tumor cell cycle arrest.

Each year, 2,500 new cases of late stage/recurrence metastasis breast cancer patients are diagnosed, 60% of them are HER2 negative breast cancer sufferers.


About masterchensays

Victor Chen, herbalist, alternative healthcare lecturer, Chinese affairs analyst, retired journalist
This entry was posted in Uncategorized. Bookmark the permalink.